ARTICLE | Clinical News
Nexavar sorafenib: Phase III started
August 25, 2008 7:00 AM UTC
The partners began the double-blind, placebo-controlled, international Phase III STORM trial to evaluate 400 mg of oral Nexavar given twice daily for up to 4 years in 1,100 patients after surgical res...